Prostate News Archive
16-Jul-2011
For Some Prostate Cancer Patients, Combo Treatment Improves Survival
WEDNESDAY, July 13 (HealthDay News) -- For men who have prostate cancer that's considered "intermediate risk," radiation plus four months of hormone therapy appears to improve survival, a new study finds. Combination Therapy May Treat Prostate Cancer
Title: Combination Therapy May Treat prostate Cancer Category: Health News Created: 7/14/2011 11:01:00 AM Last Editorial Review: 7/14/2011 Prostate Cancer Patients Live Much Longer with Hormone Therapy Added to Radiation
July 15, 2011 ? Adding short-term androgen deprivation therapy (ADT) to radiation therapy for men with early-stage, intermediate risk prostate cancer made a significant improvement in their overall survival after 10 years, according to a clinical trial supported by the National Cancer Institute (NCI), part of the National Institutes of Health. Hormone Drugs May Boost Life Expectancy for Prostate Cancer Patients
Some prostate cancer patients may improve their long-term survival chances by receiving hormone suppression drugs such as Abbott Laboratories (ABT) ? Lupron and AstraZeneca Plc (AZN) ?s Zoladex with radiation therapy, a study showed.
Back to Prostate News Archive
